X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Markets will remain closed on 15th August 2018.
We wish all our readers a Happy Independence Day!

Sensex Opens 240 Points Lower; Metal & PSU Stocks Drag
Mon, 13 Aug 09:30 am | Rini Mehta, TM Team

Asian stock markets are lower today as Chinese and Hong Kong shares fall. The Shanghai Composite is off 1.7% while the Hang Seng is down 1.8%. The Nikkei 225 is trading down by 1.6%. US stocks slid on Friday as a deepening economic crisis in Turkey dragged on bank shares and triggered a move out of riskier assets.

Back home, India share markets have opened the day on a lower note. The BSE Sensex is trading down by 239 points while the NSE Nifty is trading down by 80 points. The BSE Mid Cap index opened and BSE Small Cap index opened the day down by 0.9% & 0.7% respectively.

The rupee is currently trading at 68.95 to the US$.

Sectoral indices have opened the in on a mixed note with information technology stocks and healthcare stocks witnessing maximum buying interest. While, metal stocks and PSU stocks have opened the day in red.

In the news from the pharma sector. As per an article in a leading financial daily, Cipla has received final approval for its abbreviated new drug application (ANDA) for Atazanavir Caps 100mg, 150mg, 200mg, and 300mg from the United States Food and Drug Administration (USFDA).

According to IQVIA (IMS Health), Reyataz and its generic equivalents had US sales of approximately US$324mn for the 12-month period ending April 2018.

--- Advertisement ---
Claim Your Virtually Free Book Before We Run Out of Stock - 1,000 Copies Only

Our 220-page book, Equitymaster's Secrets: The Biggest Lessons From our Entire 20+ Years Investing Journey is available on Amazon for Rs 1,450.

But recently, we decided to publish an updated edition - with a special message on investing from Tanushree Banerjee.

And today, as a special thank you to loyal readers like you, we've decided to give away 1,000 copies of this Limited Edition hardbound book - virtually free.

But there's a catch: We can only send this book to an Indian address.

Reserve your copy by providing your Indian postal address here.
------------------------------

Cipla's Atazanavir Caps 100mg, 150mg, 200mg, and 300mg are an AB-rated generic therapeutic equivalent version of Bristol-Myers Squibb Pharma Company's, Reyataz.

It is a protease inhibitor indicated for use in combination with other antiretroviral agents for the treatment of HIV-1 infection in patients aged 6 years and older and weighing at least 15 kg.

Cipla share price opened the day up by 0.6%.

Speaking of the pharma sector, the BSE Healthcare Index has been on a roller coaster ride in the past few years. The period from 2012 to 2015 saw the index go up more than three times.

The Roller Coaster Ride of the BSE Healthcare Index

Since then it has been a painful ride downwards.

Pre-2015, pharma companies enjoyed a fairytale ride in the US market. Low labor costs, good chemistry skills, along with efficiency, ensured Indian companies could copy innovator drugs to make generic drugs at a fast pace.

The generic business had lucrative margins for all major pharma players. But the party did not last long. In the quest to supply drugs quickly, they compromised on quality at their manufacturing facilities.

The regulatory issues coupled with price erosion in US markets has impacted the business of major pharma players.

Moving on to the news from the economy. In the latest development, India's factory output grew at its fastest pace in five months at 7% in June on the back of a lower base last year due to destocking by businesses ahead of introduction of the Goods and Services Tax (GST).

The radical indirect tax reform was introduced on 1 July 2017 and disruptions continued till October. This may provide a favourable base for higher growth in the index of industrial production (IIP) in coming months.

Consumer goods, which was the worst affected sector in the run up to the introduction of GST, grew at a 21-month high of 13.1% in June. While capital goods maintained a positive growth rate at 9.6% during the month.

However, consumer non-durables continued their dismal performance, growing at 0.5% in June, reflecting poor rural demand conditions. This is expected to change with the India Meteorological Department (IMD) last week predicting favourable distribution of rainfall during August and September, the reports noted.

As per India Ratings and Research, while primary goods, one of the lead indicators of industrial growth, is exhibiting good growth and gives confidence of sustained industrial recovery, intermediate goods do not give much confidence on sustainability of the recovery.

Note that, RBI's monetary policy committee raised policy rates by 25 basis points to 6.5% earlier this month. This is the first time since October 2013 that RBI has raised rates in consecutive meetings of its rate-setting panel.

However, at Equitymaster, we do not attempt to predict how and when macroeconomic developments will unfold. Instead, we focus on the fundamentals and the underlying business strength of companies.

The ValuePro team is always on the lookout for all-weather stocks whose fortunes are not tied to economic cycles.

By the way, in the latest edition of our stock market podcast, I talk to Tanushree Banerjee, Co-head of Research, about investing in volatile markets like these. Have a question for Tanushree? Write in. Don't miss it! Sign up for our free podcast today. Visit SoundCloud, iTunes or Stitcher.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary

Equitymaster requests your view! Post a comment on "Sensex Opens 240 Points Lower; Metal & PSU Stocks Drag". Click here!

  

Stock Market Updates

CITY UNION BANK Surges by 5%; BSE BANKEX Index Up 1.0% (Today's Market)

Aug 14, 2018 03:23 PM

CITY UNION BANK share price has surged by 5% and its current market price is Rs 185. The BSE BANKEX is up by 1.0%. The top gainers in the BSE BANKEX Index is CITY UNION BANK (up 5.1%). The top losers are SBI (down 0.1%) and HDFC BANK (down 0.1%).

PFIZER at All Time High; BSE HEALTHCARE Index Up 2.2% (Today's Market)

Aug 14, 2018 03:04 PM

PFIZER share price has hit an all time high at Rs 2,910 (up 1.7%). The BSE HEALTHCARE Index is up by 2.2%. Among the top gainers in the BSE HEALTHCARE Index today are PFIZER (up 1.7%) and SANOFI INDIA (up 0.2%). The top losers include NARAYANA HRUDAYALAYA LTD (down 0.2%) and GLENMARK PHARMA (down 0.3%).

NIIT TECHNOLOGIES at All Time High; BSE IT Index Up 0.8% (Today's Market)

Aug 14, 2018 03:01 PM

NIIT TECHNOLOGIES share price has hit an all time high at Rs 1,334 (up 3.3%). The BSE IT Index is up by 0.8%. Among the top gainers in the BSE IT Index today are NIIT TECHNOLOGIES (up 3.3%) and ORACLE FINANCIAL SERVICES (up 2.3%). The top losers include MPHASIS LTD (down 0.2%) and ZENSAR TECHNOLOGIES (down 0.7%).

JSW STEEL at All Time High; BSE METAL Index Up 0.2% (Today's Market)

Aug 14, 2018 03:01 PM

JSW STEEL share price has hit an all time high at Rs 350 (down 0.2%). The BSE METAL Index is up by 0.2%. Among the top gainers in the BSE METAL Index today are JSW STEEL (down 1.4%) and TATA STEEL (up 1.4%). The top losers include JSW STEEL (down 0.2%) and VEDANTA LTD (down 0.3%).

DABUR at All Time High; BSE FMCG Index Up 0.7% (Today's Market)

Aug 14, 2018 03:01 PM

DABUR share price has hit an all time high at Rs 453 (up 2.5%). The BSE FMCG Index is up by 0.7%. Among the top gainers in the BSE FMCG Index today are DABUR (up 2.5%) and NESTLE (up 0.7%). The top losers include BOMBAY BURMAH (down 0.2%) and RADICO KHAITAN (down 0.3%).

Sensex Up Over 240 Points; Rupee Touches Record Low (Today's Market)

Aug 14, 2018 12:30 pm

The BSE Sensex is trading up by 242 points, while the NSE Nifty is trading up by 81 points.

View More Indian Share Market News

Most Popular

How to Make Big Profits by Following India's Best Investors(The 5 Minute Wrapup)

Aug 3, 2018

In a time when stocks recommended by so-called 'gurus of the market' are crashing, let Kunal Thanvi guide you to the best gurus...and their best stocks.

The Biggest Mistake You Can Make in this Market (and 3 Stocks to Buy Now!)(Profit Hunter)

Aug 3, 2018

This price pattern can help you identify stocks on the verge of a turnaround.

Does This Indicator Tell Us the Sensex is Headed for a Correction?(Vivek Kaul's Diary)

Aug 3, 2018

To what extent have foreign flows influenced Indian stock markets? How do we see it panning out now?

Is Franklin India Smaller Companies Fund Worth Your Money(Outside View)

Aug 2, 2018

Although positioned as a small cap fund, Franklin India Smaller Companies Fund has been investing a significant portion of its assets in mid-caps along with a nominal exposure to large caps.

Why HDFC Equity Fund Disappointed Its Investors(Outside View)

Aug 9, 2018

Though popular, HDFC Equity Fund is not among the best performers anymore. Here is the reason behind its underperformance that has left investors disappointed.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

S&P BSE SENSEX


Aug 14, 2018 (Close)

MARKET STATS